Yahoo Italia Ricerca nel Web

Risultati di ricerca

  1. 15 ore fa · All three dosing arms have been completed. KELOWNA, BC / ACCESSWIRE / July 9, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug ...

  2. 1 ora fa · All three dosing arms have been completed. KELOWNA, BC / ACCESSWIRE / July 9, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the "Study") has now completed all dosing. The Study is a three-arm, crossover ...

  3. 15 ore fa · 158365a0f1ea5e628875d1c5d.2LwG9-mv_7fG1Ghw17EP3DD-NoA_-0SyTgHiaKbV5Tg.ks1kvoDrs-GeoRo3n_V9j3zJRuZzzDPmIkKDL5T4kn608GqOjfyUgISDUA ...

  4. 15 ore fa · lexx Lexaria Bioscience completes dosing in second GLP-1 human pilot study LEXX - The Fly We use cookies to improve user experience, and analyze website traffic.

  5. 15 ore fa · Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform • GlobeNewswire Inc. • 01/09/2024 01:30:00 PM ; Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs • InvestorsHub NewsWire • 01/08/2024 01:45:00 PM

  6. www.stockwatch.com › News › ItemStockwatch

    1 ora fa · Kelowna, British Columbia – July 9, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the “Study”) has now completed all dosing. The Study is a three-arm, crossover investigation ...

  7. ja.wikipedia.org › wiki › 塩屋浩三塩屋浩三 - Wikipedia

    15 ore fa · 来歴. 鹿児島県で誕生し、小学3年生で神奈川県 川崎市に転居 。. 弟の塩屋翼によると無口であり、心配していた母親が「活発な子たちの仲間入りさせたら何とかなるだろう」と1966年、小学5年生の頃無口を直させるために弟と一緒に劇団ひまわり に入れられ、子役として活動した 。